4.5 Article

The beta-isoform of the BRCA2 and CDKN1A(p21)-interacting protein (BCCIP) stabilizes nuclear RPL23/uL14

Journal

FEBS LETTERS
Volume 588, Issue 20, Pages 3685-3691

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.febslet.2014.08.013

Keywords

BCCIP; Ribosome biogenesis; Eukaryotic initiation factor 6 (eIF6); Ribosomal protein; RPL23/uL14

Funding

  1. Swiss National Science Foundation [31003A_144221]
  2. Swiss National Science Foundation (SNF) [31003A_144221] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

BRCA2 and CDKN1A(p21,CIP1)-interacting protein (BCCIP) is an evolutionary conserved protein implicated in maintenance of genome stability and cell cycle progression. Two isoforms of BCCIP with distinct C-terminal domains exist in humans. We show that mammalian BCCIP beta, but not BCCIP alpha, forms a ternary complex with the ribosomal protein RPL23/uL14 and the pre-60S transacting factor eIF6. Complex formation is dependent on an intact C-terminal domain of BCCIP beta. Depletion of BCCIP beta reduces the pool of free RPL23, and decreases eIF6 levels in nucleoli. Overexpression of BCCIP beta leads to nucleoplasmic accumulation of extra-ribosomal RPL23 and stabilizes overexpressed RPL23, suggesting that BCCIP beta functions as nuclear chaperone for RPL23. (C) 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available